129 related articles for article (PubMed ID: 11813290)
1. Differential antigenotoxic and cytoprotective effect of amifostine in idarubicin-treated mice.
de Campos Nebel M; Larripa I; González-Cid M
Environ Mol Mutagen; 2002; 39(1):3-9. PubMed ID: 11813290
[TBL] [Abstract][Full Text] [Related]
2. Anticlastogenic effect of S-2-(3-aminopropylamino) ethylphosphorothioic acid against X-rays in mice.
Mazur L
Physiol Res; 1996; 45(1):59-63. PubMed ID: 8884925
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the clastogenic effect of cyclophosphamide by WR-2721 in the bone marrow of mice.
Mazur L; Czyzewska A
Mutat Res; 1994 Sep; 309(2):219-23. PubMed ID: 7520979
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine.
Błasiak J; Gloc E; Woźniak K; Młynarski W; Stolarska M; Skórski T; Majsterek I
Chem Biol Interact; 2002 Apr; 140(1):1-18. PubMed ID: 12044557
[TBL] [Abstract][Full Text] [Related]
5. WR-2721: inhibitor of cisplatin-induced micronuclei.
Mazur L; Czyzewska A; Augustynek A
Teratog Carcinog Mutagen; 2000; 20(6):349-56. PubMed ID: 11074519
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric detection of apoptotic bone marrow cells with fractional DNA content after application of WR-2721, cyclophosphamide, cisplatin, and exposure of mice to gamma rays.
Mazur L; Czyzewska A; Bochenek M
Hum Exp Toxicol; 2002 Jun; 21(6):335-41. PubMed ID: 12195937
[TBL] [Abstract][Full Text] [Related]
7. Amifostine (WR-2721) selective protection against melphalan genotoxicity.
Buschini A; Anceschi E; Carlo-Stella C; Regazzi E; Rizzoli V; Poli P; Rossi C
Leukemia; 2000 Sep; 14(9):1642-51. PubMed ID: 10995012
[TBL] [Abstract][Full Text] [Related]
8. Effects of WR-2721 and cyclophosphamide on the cell cycle phase specificity of apoptosis in mouse bone marrow.
Mazur L; Augustynek A; Deptała A; Halicka HD; Bedner E
Anticancer Drugs; 2002 Aug; 13(7):751-8. PubMed ID: 12187332
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells.
Majsterek I; Gloc E; Blasiak J; Reiter RJ
J Pineal Res; 2005 May; 38(4):254-63. PubMed ID: 15813902
[TBL] [Abstract][Full Text] [Related]
10. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721.
Weiss JF; Hoover RL; Kumar KS
Free Radic Res Commun; 1987; 3(1-5):33-8. PubMed ID: 2854528
[TBL] [Abstract][Full Text] [Related]
11. The modulatory effect of aminothiols on the clastogenic activity of X-rays assayed by the vivo mouse micronucleus test.
Mazur L
Folia Biol (Krakow); 1996; 44(1-2):55-9. PubMed ID: 9008427
[TBL] [Abstract][Full Text] [Related]
12. Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells.
Błasiak J; Gloc E; Młynarski W; Drzewoski J; Skórski T
Leuk Res; 2002 Dec; 26(12):1093-6. PubMed ID: 12443881
[TBL] [Abstract][Full Text] [Related]
13. Influence of chlorpromazine, bleomycin and WR-2721 singly or in combination on the formation of radiation-induced micronuclei in mice bone marrow.
Jagetia GC
Strahlenther Onkol; 1994 Nov; 170(11):648-53. PubMed ID: 7526477
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical analysis of apoptotic bone marrow cells after treatment of mice with WR-2721 and chemotherapeutic drugs.
Mazur L; Czyzewska A
Folia Histochem Cytobiol; 2001; 39(2):63-6. PubMed ID: 11374841
[TBL] [Abstract][Full Text] [Related]
15. Amifostine can differentially modulate DNA double-strand breaks and apoptosis induced by idarubicin in normal and cancer cells.
Wozniak K; Gloc E; Morawiec Z; Blasiak J
Exp Oncol; 2008 Mar; 30(1):22-8. PubMed ID: 18438337
[TBL] [Abstract][Full Text] [Related]
16. TEL/JAK2 tyrosine kinase inhibits DNA repair in the presence of amifostine.
Gloc E; Warszawski M; Młynarski W; Stolarska M; Hoser G; Skorski T; Błasiak J
Acta Biochim Pol; 2002; 49(1):121-8. PubMed ID: 12136932
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells.
Buschini A; Alessandrini C; Martino A; Pasini L; Rizzoli V; Carlo-Stella C; Poli P; Rossi C
Biochem Pharmacol; 2002 Mar; 63(5):967-75. PubMed ID: 11911849
[TBL] [Abstract][Full Text] [Related]
18. Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) test.
Aydemir N; Sevim N; Celikler S; Vatan O; Bilaloglu R
Mutat Res; 2009; 679(1-2):1-5. PubMed ID: 19712749
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in bone marrow cells after treatment of mice with WR-2721 and gamma-rays: relationship to the cell cycle.
Mazur L; Augustynek A; Halicka HD; Deptała A
Cell Biol Toxicol; 2003 Feb; 19(1):13-27. PubMed ID: 12661984
[TBL] [Abstract][Full Text] [Related]
20. Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice.
Attia SM; Alshahrani AY; Al-Hamamah MA; Attia MM; Saquib Q; Ahmad SF; Ansari MA; Nadeem A; Bakheet SA
Toxicol Sci; 2017 Nov; 160(1):161-172. PubMed ID: 28973540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
